
Elix, an AI Drug Discovery Company, and Tohoku University Enter Joint Research Agreement to Advance AI Drug Discovery
TOKYO, JAPAN, October 2, 2025 /EINPresswire.com/ -- Elix, Inc. (CEO: Shinya Yuki / Headquarters: Tokyo; hereinafter “Elix”) and the Graduate School of Life Sciences at Tohoku University (Dean: Kouki Hikosaka / Headquarters: Miyagi; …